Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

CD8dim and NKG2D expression defines related subsets of CD4+ T cells in HIV-infected patients with worse prognostic factors.

Alonso-Arias R, López-Vázquez A, Diaz-Peña R, Sampere A, Tricas L, Asensi V, Rodrigo L, López-Larrea C.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):390-8. doi: 10.1097/FTD.0b013e3181679015.

PMID:
19461524
2.

Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus.

Sáez-Borderías A, Gumá M, Angulo A, Bellosillo B, Pende D, López-Botet M.

Eur J Immunol. 2006 Dec;36(12):3198-206.

3.

NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.

Fausther-Bovendo H, Wauquier N, Cherfils-Vicini J, Cremer I, Debré P, Vieillard V.

AIDS. 2008 Jan 11;22(2):217-26.

PMID:
18097224
4.

Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.

Mercier F, Boulassel MR, Yassine-Diab B, Tremblay C, Bernard NF, Sekaly RP, Routy JP.

Clin Exp Immunol. 2008 Apr;152(1):72-80. doi: 10.1111/j.1365-2249.2008.03610.x. Epub 2008 Feb 14.

5.

CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.

Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, Dulphy N, Caillat-Zucman S, Paul P, Gornet JM, Douay C, Ravet S, Tamouza R, Charron D, Lémann M, Mayer L, Toubert A.

Gastroenterology. 2007 Jun;132(7):2346-58. Epub 2007 Mar 16.

PMID:
17570210
6.

Phenotypic and functional characterization of HIV-1-specific CD4+CD8+ double-positive T cells in early and chronic HIV-1 infection.

Howe R, Dillon S, Rogers L, Palmer B, MaWhinney S, Blyveis N, Schlichtemeier R, D'Souza M, Ingoldby L, Harwood JE, Rietmeijer C, Ray G, Connick E, Wilson CC.

J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):444-56.

PMID:
19360930
7.

Correlation of T-lymphocyte subpopulations with immunological markers in HIV-1-infected Indian patients.

Kaushik S, Vajpayee M, Sreenivas V, Seth P.

Clin Immunol. 2006 Jun;119(3):330-8. Epub 2006 Feb 14.

PMID:
16476571
8.

Immunologic features of HIV-1-infected women on HAART at delivery.

Ono E, Dos Santos AM, Machado DM, Succi RC, Amed AM, Salomão R, Kallás EG, de Moraes-Pinto MI.

Cytometry B Clin Cytom. 2008 Jul;74(4):236-43. doi: 10.1002/cyto.b.20418.

9.

CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.

Kolber MA.

AIDS. 2008 Oct 1;22(15):1937-41. doi: 10.1097/QAD.0b013e32830f97e2.

PMID:
18784457
10.

Extrathymic CD4/CD8 double positive T cells.

Zuckermann FA.

Vet Immunol Immunopathol. 1999 Dec 15;72(1-2):55-66. Review.

PMID:
10614493
11.

Benign monoclonal expansion of CD8+ lymphocytes in HIV infection.

Smith PR, Cavenagh JD, Milne T, Howe D, Wilkes SJ, Sinnott P, Forster GE, Helbert M.

J Clin Pathol. 2000 Mar;53(3):177-81.

12.

Immunophenotypic patterns of CD8+ T cell subsets expressing CD8alphaalpha and IL-7Ralpha in viremic, aviremic and slow progressor HIV-1-infected subjects.

Boulassel MR, Mercier F, Gilmore N, Routy JP.

Clin Immunol. 2007 Aug;124(2):149-57. Epub 2007 Jun 11.

PMID:
17560832
13.

Evaluation of antigen-specific responses using in vitro enriched T cells.

Jones N, Agrawal D, Elrefaei M, Hanson A, Novitsky V, Wong JT, Cao H.

J Immunol Methods. 2003 Mar 1;274(1-2):139-47.

PMID:
12609540
14.

Cytotoxic CD4 T cells in viral hepatitis.

Aslan N, Yurdaydin C, Wiegand J, Greten T, Ciner A, Meyer MF, Heiken H, Kuhlmann B, Kaiser T, Bozkaya H, Tillmann HL, Bozdayi AM, Manns MP, Wedemeyer H.

J Viral Hepat. 2006 Aug;13(8):505-14.

PMID:
16901280
15.

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.

Lim A, French MA, Price P.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):248-57. doi: 10.1097/QAI.0b013e3181a74fad.

PMID:
19363449
16.

TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors.

Maccalli C, Scaramuzza S, Parmiani G.

Cancer Immunol Immunother. 2009 May;58(5):801-8. doi: 10.1007/s00262-008-0635-x. Epub 2008 Dec 17. Review.

PMID:
19089424
17.

The expansion of CD8 lymphocytes using T cell receptor variable gene products during HIV infection.

De Paoli P, Caffau C, D'Andrea M, Ceolin P, Simonelli C, Tirelli U, Santini G.

Clin Exp Immunol. 1993 Dec;94(3):486-9.

18.

Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

Lopez-Hoyos M, Bartolome-Pacheco MJ, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM.

Ann Rheum Dis. 2004 Jan;63(1):54-60.

19.

Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects.

Carvalho KI, Maeda S, Marti L, Yamashita J, Haslett PA, Kallas EG.

Immunology. 2008 Jun;124(2):206-14. doi: 10.1111/j.1365-2567.2007.02756.x. Epub 2008 Feb 12.

20.

Age-dependent accumulation of monoclonal CD4+CD8+ double positive T lymphocytes in the peripheral blood of the elderly.

Ghia P, Prato G, Stella S, Scielzo C, Geuna M, Caligaris-Cappio F.

Br J Haematol. 2007 Dec;139(5):780-90.

PMID:
18021092

Supplemental Content

Support Center